The EPO granted patent EP3804733A1 to Sumitomo Seika Chemicals Co., Ltd. for a composition for treating inflammatory gastrointestinal disorders. The patent covers the therapeutic formulation and its medical application. Inventors include TAKAGI, Tomohisa, NAITO, Yuji, MIURA, Katsura, and SAKAUE, Shigeki. The designation extends to all EU contracting states including Germany, France, the United Kingdom, Italy, Spain, and other European Patent Convention members.

Organizations developing competing therapeutic compositions for inflammatory GI disorders should conduct patent freedom-to-operate analyses to avoid potential infringement. This publication does not impose regulatory compliance obligations but represents intellectual property that may affect competitive dynamics in the pharmaceutical space.